News for Clover Health Investments, Corp. (CLOVW)

WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. ('Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) ('Clover,” 'Clover Health” or the 'Company”) and a leading AI-powered physician-enablement platform, today announced the appointment of Vicky Bruner as Vice President of Operations.

On June 30, 2025, BlackRock, Inc. (Trades, Portfolio) executed a significant transaction involving Clover Health Investments Corp. The firm added 19,445,972 sha

Clover Health Investments, Corp. (NASDAQ:CLOV) is one of the Best American Penny Stocks to Buy According to Analysts. On July 9, Clover Health Investments, Corp. (NASDAQ:CLOV) announced a new pharmacy pilot program in New Jersey. The new program is being launched in partnership with IPC Digital Health, which connects independent community pharmacies across the state. The […]

PR NewswireVANCOUVER, BC, July 22, 2025 USA News Group News CommentaryIssued on behalf of Avant Technologies Inc.VANCOUVER, BC, July 22, 2025 /PRNewswire/

Shares of Medpace Holdings, Inc. MEDP rose sharply in pre-market trading after the company reported strong financial results for the second quarter and raised i...

Summary Clover Health Investments Corp (CLOV), a technology-driven healthcare company, announced on July 21, 2025, that its Chief Financial Officer, Peter Kuipe

Clover Health (CLOV) CFO to present at Canaccord Genuity's 45th Annual Growth Conference. Presentation scheduled for August 12, 2025, at 11:00 a.m. East

WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ('Clover,” 'Clover Health” or the 'Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 11:00 a.m. Eastern Time.

Summary Clover Health Investments Corp (CLOV), a company focused on enabling physicians and improving healthcare access for Medicare beneficiaries, announced on

Clover Health (CLOV) has appointed Joseph Oldakowski as the new Vice President of Finance and Controller. In his new position, Oldakowski will report directly t

WILMINGTON, Del., July 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. ( CLOV) (”œClover Health”), a physician enablement company bringing ac

Clover Health (CLOV) appoints Joseph Oldakowski as Vice President of Finance and Controller. Oldakowski brings nearly two decades of healthcare and insu

Clover Health Investments, Corp. (NASDAQ:CLOV) is one of the 13 Best Healthcare Stocks to Buy Under $10. On July 9, Clover Health Investments, Corp. (NASDAQ:CLOV) announced the launch of a new community-based pharmacy pilot program across New Jersey, built in partnership with IPC Digital Health. The initiative aims to help seniors in managing their medications and improve […]

Clover Health (CLOV) has introduced a new pharmacy program aimed at enhancing healthcare for seniors in New Jersey. Collaborating with IPC Digital Health, the i

Summary Clover Health Investments Corp (CLOV), a prominent Medicare Advantage company, announced on July 9, 2025, the initiation of a new community-based pharma

WILMINGTON, Del., July 09, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. ( CLOV) (”œClover Health”), a leading Medicare Advantage company commi

Clover Health (CLOV) partners with IPC Digital Health to launch a community pharmacy program in New Jersey. Program utilizes AI-powered tools for monito

Clover Health Investments, Corp. (NASDAQ:CLOV) is one of the 13 Stocks Under $5 With High Upside Potential. In a report released on May 7, Matt Hewitt from Craig-Hallum reiterated a Buy rating on Clover Health Investments, Corp. (NASDAQ:CLOV) with a price target of $6.00. The company reported notable fiscal Q1 2025 results that support this optimistic […]

On July 1, Ralph Schlosstein, Evercore chairman emeritus and BlackRock co-founder, appeared on CNBC's 'Closing Bell Overtime' to discuss his outlook for markets heading into the second half of 2025.